Chemicals & Advanced Materials Global On demand · 24-48h

Global Animal Growth Promoter Market Strategic Research Report

Global Animal Growth Promoter Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Animal Growth Promoter Market
$11.51B2025
3.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Hormonal Substances, Antibiotics, Enzyme Preparations, Others

By Application: Pig Farming, Cattle and Sheep, Aquaculture, Poultry, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cargill Animal Health, Royal DSM N.V., Elanco Animal Health, Zoetis, Inc., Alltech, Inc., Bayer Animal Health, Kemin, VTR BIOTECH, DuPont Animal Nutrition, Novozymes, Merck Animal Health, Biomin, Novus International, Inc., BASF SE, Chr.Hansen, New Hope Liuhe, China National Veterinary Drug Group Corporation, Jinxinnong, Haida Group, Shen Nong Development, Zhengbang Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 156 pages
Market size 2025
$11.51B
Billion USD
Forecast CAGR
3.6%
2025-2032
Forecast 2032
$14.7B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Animal Growth Promoter market size is predicted to grow from US$ 11,510 million in 2025 to US$ 14,710 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.

Animal growth promoters are substances used to enhance the growth rate, feed efficiency, and overall production performance of animals. The product range of growth promoters mainly includes hormones, antibiotics, beta-agonists, and enzymes. These substances work on various physiological mechanisms within the animal’s body, thereby accelerating the growth process or improving their health condition. Common animal growth promoters include growth hormones, feed antibiotics, and lean meat hormones.

1. Hormonal Substances: Such as growth hormones (e.g., recombinant bovine growth hormone), which help improve the growth rate and muscle mass of animals.

2. Antibiotics: Used to enhance immunity, reduce disease occurrence, and indirectly improve growth efficiency.

3. Beta-Agonists: Such as clenbuterol, which promote fat breakdown in the animal’s body, reduce fat accumulation, and increase lean meat proportion.

4. Enzyme Preparations: These help improve the digestive absorption ability of animals, enhancing feed utilization and indirectly promoting growth.

Animal growth promoters are widely used in the livestock industry, especially in the farming of poultry, pigs, and cattle. Their main function is to increase production efficiency and reduce feeding costs. However, with the growing consumer health awareness and concerns about food safety, the use of animal growth promoters has come under increasing scrutiny and regulation.

The market for animal growth promoters is experiencing significant growth opportunities due to factors such as the increasing global population and rising demand for high-quality animal protein. Below are some key drivers and trends:

1. Market Development Opportunities and Key Drivers:

Global Food Demand Growth: The increase in global population has led to a rise in the demand for animal protein, which in turn boosts the consumption of meat and dairy products, driving the expansion of the animal growth promoter market.

Need for Improved Farming Efficiency: The livestock industry is under pressure to improve efficiency and reduce costs, and the use of animal growth promoters can help enhance productivity with limited resources.

Technological Advancements: With the continuous development of genetic engineering and biotechnology, new growth promoters and more precise feed additives are emerging, further driving market growth.

2. Market Risks:

Antibiotic Resistance: The use of antibiotics as growth promoters can lead to the development of antibiotic resistance, which poses a risk to public health. Many countries have implemented stricter regulations on antibiotic use.

Consumer Health and Food Safety Concerns: Consumers are cautious about the safety and potential health impacts of growth promoters (especially hormones and antibiotics), which may influence market demand.

3. Market Concentration: The market for animal growth promoters is relatively concentrated, with a few large chemical and biotechnology companies dominating the sector. These companies have strong competitive advantages in terms of technology development, product innovation, and market promotion.

4. Downstream Demand Trends:

Demand for Meat and Dairy Products: As the middle class grows and the demand for high-protein foods increases, the demand for meat and dairy products continues to rise, directly driving the demand for animal growth promoters.

Growing Demand for Natural and Additive-Free Products: More consumers are choosing products that are free from antibiotics and hormones, which impacts the use of growth promoters in the market and has led to the development of natural alternatives.

5. Latest Technologies:

Gene Editing Technologies: Technologies like CRISPR are being used to develop more targeted growth promoters or technologies that enhance animal immunity.

Biological Feed Additives: As environmental and health concerns rise, the application of biological feed additives (such as probiotics and enzymes) is increasing, presenting potential alternatives to traditional chemical growth promoters.

This report presents a comprehensive overview of the global Animal Growth Promoter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Hormonal Substances
  • Antibiotics
  • Enzyme Preparations
  • Others

Segment by Application

  • Pig Farming
  • Cattle and Sheep
  • Aquaculture
  • Poultry
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal Growth Promoter market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pig Farming, Cattle and Sheep, Aquaculture evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Animal Growth Promoter Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$11.51B
2025
Forecast
$14.7B
2032
CAGR
3.6%
2025–2032
Regions
5
global
Key companies
Cargill Animal HealthRoyal DSM N.V.Elanco Animal HealthZoetis, Inc.Alltech, Inc.Bayer Animal HealthKeminVTR BIOTECH
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Hormonal SubstancesAntibioticsEnzyme PreparationsOthers
By Application
Pig FarmingCattle and SheepAquaculturePoultryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Hormonal Substances
  • 3.1.3 Antibiotics
  • 3.1.4 Enzyme Preparations
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pig Farming
  • 4.1.3 Cattle and Sheep
  • 4.1.4 Aquaculture
  • 4.1.5 Poultry
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Cargill Animal Health
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Royal DSM N.V.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Elanco Animal Health
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zoetis, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Alltech, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bayer Animal Health
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Kemin
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 VTR BIOTECH
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 DuPont Animal Nutrition
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Novozymes
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Merck Animal Health
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Biomin
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Novus International, Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 BASF SE
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Chr.Hansen
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 New Hope Liuhe
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 China National Veterinary Drug Group Corporation
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Jinxinnong
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Haida Group
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shen Nong Development
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Zhengbang Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Animal Growth Promoter market?
The global Animal Growth Promoter market is estimated at US$ 11.51 billion in 2025 (base year) and is projected to reach US$ 14.71 billion by 2032.
How fast is the Animal Growth Promoter market expected to grow?
The market is expected to grow at a CAGR of 3.6% from 2026 to 2032, expanding from US$ 11.51 billion in 2025 to US$ 14.71 billion in 2032, roughly 1.3 times its base-year value.
What does the Animal Growth Promoter market cover?
Animal growth promoters are substances used to enhance the growth rate, feed efficiency, and overall production performance of animals. The product range of growth promoters mainly includes hormones, antibiotics, beta-agonists, and enzymes. These substances work on various physiological mechanisms within the animal’s body, thereby accelerating the growth process or improving their health condition.
How is the Animal Growth Promoter market segmented by type?
By type, the market is segmented into Hormonal Substances, Antibiotics, Enzyme Preparations and Others.
What are the key applications of Animal Growth Promoter?
Key applications covered include Pig Farming, Cattle and Sheep, Aquaculture, Poultry and Others.
Which companies are profiled in the Animal Growth Promoter market report?
Key players profiled include Cargill Animal Health, Royal DSM N.V., Elanco Animal Health, Zoetis, Alltech, Bayer Animal Health, Kemin and VTR BIOTECH, among 21 companies covered in total.
What geographies does the Animal Growth Promoter market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Animal Growth Promoter?
Global Food Demand Growth: The increase in global population has led to a rise in the demand for animal protein, which in turn boosts the consumption of meat and dairy products, driving the expansion of the animal growth promoter market.
Who should buy the Animal Growth Promoter market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pig Farming, Cattle and Sheep and Aquaculture, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Animal Growth Promoter market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.